Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of genetic markers to determine risk for prostate cancer at prostate biopsy.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2005

Nam Robert K, Zhang William W, Jewett Michael A S, Trachtenberg John, Klotz Laurence H, Emami Marjan, Sugar Linda, Sweet Joan, Toi Ants, Narod Steven A

Abstract excerpt

PURPOSE: We examined a panel of 13 polymorphisms in 13 different genes to determine whether specific genotypes can help predict prostate cancer at the time of biopsy among men prescreened with prostate-specific antigen and digital rectal exam. EXPERIMENTAL DESIGN: We examined 2,088 consecutive men who were referred for prostate biopsy from 1997 to 2003. Thirteen genes were examined, including TNF308, GSTT1, KLK2,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Genetic Markers

Share to Odds Ratio

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 16322300
DOI: 10.1158/1078-0432.CCR-05-1226

Genes

GSTT1
KLK2
MSR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of genetic markers to determine risk for prostate cancer at prostate biopsy.PMID 16322300Read ↗

Utility of incorporating genetic variants for the early detection of prostate cancer.Semantic proximity Read ↗

A genetic-based approach to personalized prostate cancer screening and treatment.Semantic proximity Read ↗

Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.Semantic proximity Read ↗

Clinical consequences of a genetic predisposition toward higher benign prostate-specific antigen levels.Semantic proximity Read ↗

A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk.Semantic proximity Read ↗

Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.Semantic proximity Read ↗

Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination.Semantic proximity Read ↗

Multigene panels in prostate cancer risk assessment: a systematic review.Semantic proximity Read ↗

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.Semantic proximity Read ↗

When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.Semantic proximity Read ↗

Carriage of mutations R462Q (rs 486907) and D541E (rs 627928) of the RNASEL gene and risk factors in patients with prostate cancer in Burkina Faso.Semantic proximity Read ↗

TNF polymorphisms and prostate cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.